NORAD and colorectal cancer: Wang et al.6demonstrated significantly higher levels of serum NORAD in patients with colorectal cancer (1.495 ± 1.3024) compared to healthy controls (0.492 ± 0.681) and patients with benign colorectal diseases (1.021 ± 0.975).